89bio rises after $250 mln equity haul

Akero Therapeutics

29/01/2025 14:09

**  Shares of 89Bio  ETNB.O  up 1.7% at $9.16 premarket
after co secures equity raise
  
    ** San Franscisco-based firm late Tues  ~28.6 mln shares,
including 6.9 mln pre-funded warrants, at $8.75 for $250 mln
gross proceeds
  
    ** Co plans to use net offering proceeds to fund its lead
drug candidate, 
  
    
      
    
    On Mon, 
    ETNB shares 
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
    
      
    
  

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))